Tokio Marine Asset Management’s Avidity Biosciences RNAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-74,300
Closed -$5.36M 528
2025
Q4
$5.36M Buy
+74,300
New +$4.8M 0.18% 98

Other funds holding RNAM

Tokio Marine Asset Management's RNAM Position: Q1 2026 in Review

Tokio Marine Asset Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 74,300 shares — an estimated $5.36M sold.

Tokio Marine Asset Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $5.36M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Tokio Marine Asset Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Tokio Marine Asset Management sold 74,300 Avidity Biosciences shares in Q1 2026, an estimated $5.36M.
  • Tokio Marine Asset Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Tokio Marine Asset Management's Avidity Biosciences position peaked at $5.36M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Tokio Marine Asset Management's 13F filing for Q1 2026, filed 13 May 2026.